Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 23.70 | (8.01) | (17.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | 30.00 | (17.00) | 17.00¢ | 7.4 | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Biotechs Get Rival Deals To Build Anthrax Vaccine | 27-Sep-2008 | Washington Post |
| Local Briefing | 21-Mar-2008 | Washington Post |
| Currency | US Dollars |
| Share Price | $ 1.26 |
| Change Today | $ -0.05 |
| % Change | -3.82 % |
| 52 Week High | $3.94 |
| 52 Week Low | $1.08 |
| Volume | 267,290 |
| Shares Issued | 48.33m |
| Market Cap | $60.90m |
| Beta | 1.01 |
| RiskGrade | 324 |
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| Time | Volume / Share Price |
| 16:16 | 7,468 @ $1.26 |
| 16:15 | 100 @ $1.26 |
| 16:15 | 143 @ $1.26 |
| 16:14 | 100 @ $1.26 |
| 16:14 | 100 @ $1.26 |
You are here: research